Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch

  1. Andreas Trumpp,
  2. Michael J. Depew,
  3. John L.R. Rubenstein,
  4. J. Michael Bishop, and
  5. Gail R. Martin
  1. G.W. Hooper Foundation, Department of Microbiology, School of Medicine, University of California at San Francisco (UCSF), San Francisco, California 94143-0552 USA; Nina Ireland Laboratory of Developmental Neurobiology, Department of Psychiatry, School of Medicine, UCSF, San Francisco, California 94143-0984 USA; Department of Anatomy and Program in Developmental Biology, School of Medicine, UCSF, San Francisco, California 94143-0452 USA

Abstract

In mammals, the first branchial arch (BA1) develops into a number of craniofacial skeletal elements including the jaws and teeth. Outgrowth and patterning of BA1 during early embryogenesis is thought to be controlled by signals from its covering ectoderm. Here we used Cre/loxP technology to inactivate the mouseFgf8 gene in this ectoderm and have obtained genetic evidence that FGF8 has a dual function in BA1: it promotes mesenchymal cell survival and induces a developmental program required for BA1 morphogenesis. Newborn mutants lack most BA1-derived structures except those that develop from the distal-most region of BA1, including lower incisors. The data suggest that the BA1 primordium is specified into a large proximal region that is controlled by FGF8, and a small distal region that depends on other signaling molecules for its outgrowth and patterning. Because the mutant mice resemble humans with first arch syndromes that include agnathia, our results raise the possibility that some of these syndromes are caused by mutations that affect FGF8 signaling in BA1 ectoderm.

Keywords

Footnotes

  • Present address: Swiss Institute for Experimental Cancer Research (ISREG), CH 1066, Epalinges, Lausanne, Switzerland.

  • Corresponding author.

  • E-MAIL gmartin{at}itsa.ucsf.edu; FAX (415) 476-3493

    • Received September 13, 1999.
    • Accepted October 19, 1999.
| Table of Contents

Life Science Alliance